Lataa...
Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
Dasatinib is associated with increased risk of bleeding among patients with chronic myeloid leukemia, even in the absence of thrombocytopenia, suggesting the presence of a hemostatic defect. We tested platelet aggregation in 91 patients with chronic myeloid leukemia in chronic phase either off-thera...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3952950/ https://ncbi.nlm.nih.gov/pubmed/19414863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-180604 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|